Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Rare Disease Patients: Placebo Controls, Sham Surgeries Not Appropriate For Gene Therapy Trials
Dec 20 2022
•
By
Derrick Gingery
A rare disease group shared focus group data indicating they would not participate in gene therapy trials with placebo controls. • Source: Shutterstock
More from Clinical Trials
More from R&D